Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1984-11-19
1987-06-02
Schenkman, Leonard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
514178, 514843, A61K 3156
Patent
active
046704264
ABSTRACT:
There are provided post-coital contraceptive pharmaceutical compositions comprising a blocker of progesterone activity (antiprogesterone) at comparatively high dosage, or a combination of such blocker of progesterone activity with a blocker of estrogen and of progesterone synthesis.
REFERENCES:
patent: 4386085 (1983-05-01), Teutsch et al.
patent: 4459235 (1984-07-01), Chinn et al.
patent: 4536401 (1985-08-01), Neef et al.
Cunningham et al., "J. Clin. Endocrinol. Met." (1975), vol. 40 (2), pp. 265-267, an article titled--"Antiovulatory Activity of Synthetic Corticoids" as abstracted in Chem. Abs. 82 (25), par. 165,224(g).
Joseph Shalom
Zor Uriel
Lipovsky Joseph A.
Schenkman Leonard
Yeda Research and Development Co. Ltd.
LandOfFree
Interruption of fertility in mammals by post-coital pills does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Interruption of fertility in mammals by post-coital pills, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Interruption of fertility in mammals by post-coital pills will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-613694